Study of Novel Types of Familial Diabetes Insipidus
NCT00004364 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 5
Last updated 2006-02-22
Summary
OBJECTIVES:
I. Define the phenotype and genotype of previously unrecognized types of familial diabetes insipidus (FDI) in kindreds with atypical or novel forms of FDI.
Conditions
- Diabetes Insipidus
Interventions
- DRUG
-
desmopressin
Sponsors & Collaborators
- collaborator OTHER
-
National Center for Research Resources (NCRR)
lead NIH
Principal Investigators
-
Gary L. Robertson · Northwestern University
Eligibility
- Min Age
- 6 Months
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1995-12-31
More Related Trials
-
Subclassification of the Syndrome of Inappropriate ADH Secretion
NCT01341665 ·Status: COMPLETED
-
Copeptin in the Diagnosis and Differential Diagnosis of Diabetes Insipidus. The CoSIP-Study
NCT00757276 ·Status: COMPLETED
-
Use of Copeptin Measurement After Arginine Infusion for the Differential Diagnosis of Diabetes Insipidus - the CARGOx Study
NCT03572166 ·Status: COMPLETED ·Phase: NA
-
Desmopressin as a Therapy for Bedwetting in Children With Sickle Cell Disease
NCT02636387 ·Status: TERMINATED
-
Adrenocorticotropic Hormone Stimulation in Postural Orthostatic Tachycardia Syndrome (POTS)
NCT01764711 ·Status: COMPLETED ·Phase: NA
-
Study of the Relationship Between Calcium Levels and Intact Parathyroid Hormone (iPTH) in Adults With Repaired or Palliated Conotruncal Cardiac Defects
NCT00004361 ·Status: COMPLETED
-
The Trend of Copeptin Levels and Its Clinical Value for Postoperative CDI in Pediatric Patients After NSI in ICU
NCT06742060 ·Status: RECRUITING
-
Diagnosis of Central Adrenal Insufficiency in Patients With Prader-Willi Syndrome
NCT02368379 ·Status: COMPLETED ·Phase: NA
-
Evaluation of A Clinical Diagnostic Test for CRDS
NCT06188689 ·Status: RECRUITING ·Phase: NA
-
Urinary Aquaporine 2 in Patients With Syndrome of Inappropriate ADH-secretion Caused by Treatment With Antiepileptic Medicine
NCT00298753 ·Status: WITHDRAWN ·Phase: PHASE4
-
Phase II Pilot Study of Early Cortisol Replacement to Prevent Bronchopulmonary Dysplasia
NCT00004669 ·Status: COMPLETED ·Phase: PHASE2
-
Establishment of a Database for Long-Term Monitoring of Patients With Nephropathic Cystinosis
NCT00004312 ·Status: COMPLETED
-
Desmopressin for Bedwetting in Children With SCD
NCT04420585 ·Status: TERMINATED ·Phase: PHASE4
-
The Pharmacology and Hemodynamics of Dexmedetomidine in Children With Congenital Heart Disease
NCT00480740 ·Status: COMPLETED ·Phase: PHASE3
-
Diagnosis of Pheochromocytoma
NCT00004847 ·Status: RECRUITING ·Phase: PHASE1
-
Dyskinesia, Heterotaxy and Congenital Heart Disease
NCT00608556 ·Status: COMPLETED
-
Desmopressin Melt: Impact on Sleep and Daytime Functioning
NCT01645475 ·Status: COMPLETED ·Phase: PHASE4
-
Tolvaptan Versus Fluid Restriction in SIADH
NCT04119206 ·Status: COMPLETED
-
Assessment of ShuntCheck Performance Characteristics in Asymptomatic Patients With Normal Pressure Hydrocephalus
NCT04011566 ·Status: RECRUITING
-
Congenital Adrenal Hyperplasia: Calcium Channels as Therapeutic Targets
NCT00000102 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Nesiritide Use Following Cardiac Surgery in Infants
NCT00281671 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Urinary Aquaporin 2 and Expression of the NPHS2 Gene in Adults Suffering From Nephrotic Syndrome
NCT00286910 ·Status: COMPLETED
-
The Role of the Glymphatic System Avaluated Thourgh mr Imaging in the Diagnosis and Management of NPH
NCT06857136 ·Status: COMPLETED
-
Adrenal Responsiveness During the Perioperative Period in Children Undergoing Congenital Cardiac Surgery
NCT01839812 ·Status: COMPLETED ·Phase: PHASE1
-
To Assess the Efficacy of Midodrine in Prevention of Cirrhosis Related Complications in Children Awaiting Liver Transplantation.
NCT05287100 ·Status: COMPLETED ·Phase: NA